In our last issue, Steven Kelman of Harvard’s Kennedy School of Government criticized cost-benefit analysis from the perspective not of economics but of ethical theory. He concluded that in health, ...
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
Under both the Donald Trump and Joe Biden administrations, the U.S. government has had a seemingly unquenchable thirst for national security regulations limiting investment, trade, and information ...
The world of microeconomics and business decision-making hinges upon a key concept: marginal cost. In the simplest terms, marginal cost represents the expense incurred to produce an additional unit of ...
Air pollution contributes to the development of numerous adverse human health outcomes. The Environmental Protection Agency’s Environmental Benefits Mapping and Analysis Program–Community Edition ...
SAN FRANCISCO, CA—Earlier results from the COAPT trial have established that use of a MitraClip (Abbott) on top of guideline-directed medical therapy (GDMT) cuts mortality and heart failure ...
The inclusion of dynamic drug pricing in cost-effectiveness analysis is important for value assessments of new drugs. The drug price-related provisions of the Inflation Reduction Act make the case for ...
EV aficionados will tell you that electric vehicles are cheaper to fuel and maintain, so that means they must be cheaper to own and operate. EV skeptics will counter with the premium pricing of many ...
In 2022, our colleagues at the International Rescue Committee (IRC) were struggling to address one of the world’s most profound child health crises: hundreds of thousands of children in Chad suffering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results